Holen Sie sich die Stockscreener-App
146.95
3.23%
4.60
Vorhandelsmarkt:
144.32
-2.63
-1.79%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt BDX?
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$142.35
Offen:
$142
24-Stunden-Volumen:
3.99M
Relative Volume:
1.42
Marktkapitalisierung:
$40.49B
Einnahmen:
$21.37B
Nettoeinkommen (Verlust:
$1.41B
KGV:
37.26
EPS:
3.9437
Netto-Cashflow:
$3.07B
1W Leistung:
-0.38%
1M Leistung:
-7.31%
6M Leistung:
-23.15%
1J Leistung:
-17.00%
1-Tages-Spanne:
$141.82
$148.21
1-Wochen-Bereich:
$141.82
$148.21
52-Wochen-Spanne:
$141.82
$213.08
Becton Dickinson Co Stock (BDX) Company Profile
Firmenname
Becton Dickinson Co
Sektor
Telefon
(201) 847-6800
Adresse
ONE BECTON DR, FRANKLIN LAKES
Compare BDX vs ISRG, ALC, MDLN, RMD
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
BDX
Becton Dickinson Co
|
146.95 | 39.22B | 21.37B | 1.41B | 3.07B | 3.9437 |
ISRG
Intuitive Surgical Inc
|
441.58 | 155.80B | 10.58B | 3.00B | 2.83B | 8.2437 |
ALC
Alcon Inc
|
66.28 | 32.17B | 10.63B | 819.00M | 1.59B | 1.6577 |
MDLN
Medline Inc
|
37.70 | 30.46B | 29.14B | 1.07B | 1.05B | 1.1956 |
RMD
Resmed Inc
|
207.78 | 29.61B | 5.54B | 1.52B | 1.74B | 10.37 |
Becton Dickinson Co Stock (BDX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-04-10 | Fortgesetzt | Goldman | Neutral |
| 2026-02-10 | Fortgesetzt | Barclays | Overweight |
| 2026-02-03 | Fortgesetzt | Citigroup | Buy |
| 2025-09-25 | Eingeleitet | RBC Capital Mkts | Sector Perform |
| 2025-05-22 | Herabstufung | Citigroup | Buy → Neutral |
| 2025-05-02 | Herabstufung | Goldman | Buy → Neutral |
| 2025-05-02 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2025-05-02 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2025-05-01 | Herabstufung | BofA Securities | Buy → Neutral |
| 2025-05-01 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2025-05-01 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2024-10-01 | Hochstufung | Citigroup | Neutral → Buy |
| 2024-05-30 | Eingeleitet | Goldman | Buy |
| 2023-07-24 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2023-05-30 | Fortgesetzt | Morgan Stanley | Overweight |
| 2023-05-05 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2023-04-12 | Hochstufung | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2023-01-03 | Hochstufung | BofA Securities | Neutral → Buy |
| 2022-12-12 | Hochstufung | Citigroup | Sell → Neutral |
| 2022-07-11 | Herabstufung | Citigroup | Neutral → Sell |
| 2022-06-24 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2022-03-18 | Fortgesetzt | Raymond James | Mkt Perform |
| 2022-03-02 | Fortgesetzt | BofA Securities | Neutral |
| 2021-12-08 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2021-08-06 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2021-05-25 | Eingeleitet | Barclays | Equal Weight |
| 2020-12-15 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2020-12-15 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2020-07-09 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2020-06-01 | Fortgesetzt | Goldman | Buy |
| 2020-03-05 | Eingeleitet | Citigroup | Neutral |
| 2020-02-07 | Herabstufung | Cowen | Outperform → Market Perform |
| 2020-02-07 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2020-02-07 | Herabstufung | Raymond James | Strong Buy → Outperform |
| 2020-02-06 | Herabstufung | Cowen | Outperform → Market Perform |
| 2020-01-08 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2019-05-13 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2018-12-07 | Eingeleitet | Deutsche Bank | Buy |
| 2018-10-16 | Eingeleitet | Barclays | Equal Weight |
| 2018-06-21 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2018-04-10 | Hochstufung | Citigroup | Neutral → Buy |
| 2018-01-19 | Fortgesetzt | BofA/Merrill | Buy |
| 2018-01-05 | Hochstufung | Citigroup | Sell → Neutral |
| 2018-01-05 | Eingeleitet | KeyBanc Capital Mkts | Overweight |
| 2018-01-03 | Eingeleitet | Evercore ISI | Outperform |
| 2017-12-29 | Bestätigt | Deutsche Bank | Buy |
Alle ansehen
Becton Dickinson Co Aktie (BDX) Neueste Nachrichten
A Look at Becton Dickinson & Co (BDX) After 3.2% Gain -- GF Value $194.45 vs Price $146.95 - GuruFocus
Becton Dickinson & Co. stock outperforms competitors on strong trading day - MarketWatch
Nebulizers - GlobeNewswire Inc.
Is Wall Street Bullish or Bearish on Becton, Dickinson and Company Stock? - inkl
BD Names Peter Menziuso to Lead $BD Interventional Business - citybiz
Peter Menziuso Named EVP and President, BD Interventional – Company Announcement - Financial Times
Becton, Dickinson and Company (BDX) Stock Analysis: Unveiling a 27.75% Potential Upside - DirectorsTalk Interviews
Becton Dickinson hikes profit outlook, names CFO - MSN
Becton Dickinson and Co stock (US0758871091): earnings beat and strategic focus keep medtech giant i - AD HOC NEWS
DNB Asset Management AS Has $22.28 Million Position in Becton, Dickinson and Company $BDX - MarketBeat
Northwestern Mutual Wealth Management Co. Increases Stock Position in Becton, Dickinson and Company $BDX - MarketBeat
Becton Dickinson (BDX) Delivers Solid Q2 Performance, Barclays Lifts Target - Insider Monkey
Becton Dickinson & Co(BDX) Stock Options Chain | Quotes & News - Moomoo
Becton Dickinson's (NYSE:BDX) Strong Earnings Are Of Good Quality - 富途牛牛
Global Cervical Cancer Diagnostics Market to Exhibit Growth at a CAGR of ~5% by 2034 | DelveInsight - GlobeNewswire Inc.
Becton Dickinson & Co. stock underperforms Wednesday when compared to competitors - MarketWatch
BDX Stock Price, Quote & Chart | BECTON DICKINSON AND CO (NYSE:BDX) - ChartMill
Becton, Dickinson and Company (BDX) Announces €600 Million Euro Notes Offering - GuruFocus
Becton Dickinson & Co (BDX) News Flow - Moomoo
Becton Dickinson Announces €600 Million Senior Notes Offering - TipRanks
Becton Dickinson launches €600M euro-note offering to refinance 2026 notes - TradingView
This Becton Dickinson Insider Increased Their Holding In The Last Year - Moomoo
Becton, Dickinson and Company $BDX Shares Bought by First Eagle Investment Management LLC - MarketBeat
Crossmark Global Holdings Inc. Grows Stake in Becton, Dickinson and Company $BDX - MarketBeat
May 11, 2026FWP: Filing under Securities Act Rules 163/433 of free writing prospectuses - Becton Dickinson
Is Becton Dickinson & Co (BDX) a Bargain After 4.2% Drop? GF Val - GuruFocus
Becton Dickinson & Co. stock underperforms Monday when compared to competitors - MarketWatch
BD appoints Vitor Roque as permanent CFO - MedTech Dive
Dental Needle Market Is Going to Boom |• BD (Becton Dickinson and Company) • Terumo Corporation - openPR.com
Barclays Maintains Becton Dickinson & Co(BDX.US) With Buy Rating, Maintains Target Price $204 - Moomoo
Jim Cramer on Becton, Dickinson: “The Company Showed Excellent Execution Across the Board” - Insider Monkey
Becton, Dickinson and Company Q2 Earnings Call Highlights - sharewise.com
Becton, Dickinson & Co. Hits Day High with Strong 5.87% Surge - Markets Mojo
4: Statement of changes in beneficial ownership of securities - Becton Dickinson
Becton Dickinson & Co. stock outperforms competitors despite losses on the day - MarketWatch
Becton, Dickinson Building Growth After 'Clean' Fiscal Q2 Beat, RBC Says - Moomoo
RBC Capital Maintains Becton Dickinson & Co(BDX.US) With Hold Rating, Maintains Target Price $175 - 富途牛牛
Becton, Dickinson and Company (NYSE:BDX) Q2 2026 Earnings Call Transcript - Insider Monkey
Pregnancy Detection Kits Market Analysis Report 2026 - GlobeNewswire Inc.
Research Alert: CFRA Maintains Hold Rating On Shares Of Becton, Dickinson And Company - Moomoo
Becton Dickinson (BDX) Q2 EPS Loss Tests Bullish Margin Improvement Narrative - simplywall.st
Becton Dickinson Q2 FY26 slides: EPS beat drives guidance raise By Investing.com - Investing.com South Africa
Update: Becton, Dickinson Shares Rise After Higher Fiscal Q2 Results; Vitor Roque Named as CFO - Moomoo
Becton Dickinson Lifts EPS Outlook Amid Mixed Headwinds - TipRanks
Evercore ISI Adjusts Price Target on Becton, Dickinson and Company to $190 From $180 - Moomoo
Is the options market predicting a spike in Becton Dickinson stock? - MSN
Why Is Becton Dickinson Stock Gaining Thursday?Becton Dickinson (NYSE:BDX) - Benzinga
Deals tracker: Cross Country Healthcare to be acquired for $437M - Modern Healthcare News
Becton Dickinson Q2 FY26 slides: EPS beat drives guidance raise - Investing.com
TD Cowen Maintains Becton Dickinson & Co(BDX.US) With Hold Rating, Maintains Target Price $163 - Moomoo
Earnings call transcript: Becton Dickinson Q2 2026 beats earnings expectations By Investing.com - Investing.com Australia
Finanzdaten der Becton Dickinson Co-Aktie (BDX)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.47%
0.16%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):